You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 19, October 22, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Immunologic Disorders
 •Dermatology
 •Papillomavirus, Human
 •Alert me on articles by topic

Treatment of a Bowenoid Papulosis of the Penis With Local Applications of Cidofovir in a Patient With Acquired Immunodeficiency Syndrome

Robert Snoeck, MD, PhD; Yves Van Laethem, MD; Erik De Clercq, MD, PhD; Josiane De Maubeuge, MD; Nathan Clumeck, MD, PhD

Arch Intern Med. 2001;161:2382-2384.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

We report a case of bowenoid papulosis in a patient with acquired immunodeficiency syndrome that was successfully treated with local applications of cidofovir in Beeler base. This treatment should be confirmed as a valuable nonagressive therapy for such potentially invasive viral-induced cell proliferation.


REPORT OF A CASE

A 38-year-old homosexual man with a 10-year history of human immunodeficiency virus and an 8-month history of acquired immunodeficiency syndrome presented with a fibrotic lesion of the penis in June 1996. His medical history revealed that he had been diagnosed as having herpes zoster in 1992. He was also known to be positive for hepatitis B antigen. In 1995, he was treated for clinical Pneumocystis carinii pneumonia. In October 1995, treatment with zidovudine and zalcitabine was initiated (CD4 cell count, 22/µL), followed by zidovudine and lamivudine . . . [Full Text of this Article]

COMMENT

From the Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium (Drs Snoeck and De Clercq); and the Departments of Internal Medicine (Drs Van Laethem and Clumeck) and Dermatology (Dr De Maubeuge), Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections
De Clercq
Clin. Microbiol. Rev. 2003;16:569-596.
ABSTRACT | FULL TEXT  

Successful Treatment of Bowenoid Papulosis in a 9-Year-Old Girl With Vertically Acquired Human Immunodeficiency Virus
Godfrey et al.
Pediatrics 2003;112:e73-76.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.